Ceribell, Inc. (CBLL)
18.49
+0.13
(+0.71%)
USD |
NASDAQ |
Mar 13, 16:00
18.50
+0.01
(+0.05%)
After-Hours: 20:00
Ceribell EPS Diluted (Quarterly) : -0.3634 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 1.074 |
| AtriCure, Inc. | 0.0366 |
| Boston Scientific Corp. | 0.4493 |
| Edwards Lifesciences Corp. | 0.1104 |
| Celldex Therapeutics, Inc. | -1.223 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.53M |
| Revenue (Quarterly) | 24.78M |
| Total Expenses (Quarterly) | 38.31M |
| Enterprise Value | 559.00M |
| Gross Profit Margin (Quarterly) | 87.33% |
| Profit Margin (Quarterly) | -54.58% |
| Earnings Yield | -7.90% |
| Normalized Earnings Yield | -7.903 |